Morphine in Acute Abdominal Pain

Study Overview
=================
Brief Summary
-----------------
The investigators primary outcome measure was the clinically important change in diagnostic accuracy and physical examination in the morphine vs. placebo group. After follow up information was obtained and patients data were recorded on the SPSS data chart, two blinded coauthors (general surgeon and emergency physician) determined the clinically important diagnostic accuracy and change in physical examination. They firstly defined clinically important diagnostic errors, as any disagreement between the preliminary and final diagnosis that might be expected to have adverse effect on the patient's general status. If coauthors decided an instance of diagnostic error as clinically important, this was coded diagnostic discordance for statistical analysis. While the preliminary diagnosis was determined as accurate or not different from the final diagnosis, this was coded diagnostic accuracy for statistical analysis. Secondary outcome measures included the need for rescue drugs at 30 minutes, the presence of at least one adverse event, demographic features and final diagnosis of the patients.

Conditions
-----------------
Abdominal Pain

Intervention / Treatment
-----------------
* Drug: Morphine


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Elderly (65 years or older) patients with non-traumatic UAP of less than 48 hours' duration were included in the study. Participants were required to have a UAP and report either mild or greater pain intensity on a four-point verbal rating scale (VRS) or at least 20 mm on a 100 mm visual analogue scale (VAS). Exclusion Criteria: Exclusion criteria included known allergy or contraindication to morphine, or any opioid analgesic Hemodynamic instability (systolic blood pressure less than 100 mm-Hg) Use of any analgesic within 6 hours before ED presentation Patients refused to participate to the study Incooperated to the VAS Isolated flank pain or previous study enrollment Patients with known renal, pulmonary, cardiac or hepatic failure were also excluded.

Ages Eligible for Study
-----------------
Minimum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Placebo Comparator: Placebo Group<br> | Drug: Morphine<br>* 0.1 mg/kg Intravenous bolus<br>|
| Experimental: Morphine<br> | Drug: Morphine<br>* 0.1 mg/kg Intravenous bolus<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Our primary outcome measure was the clinically important change in diagnostic accuracy and physical examination in the morphine vs. placebo group. |  |  | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
to evaluate the anal. efficacy of IV morph. vs. place. for elderly presenting to the ED with UAP and determine if it has an impact on diag. accu. and phy. exam